Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02859116 · ClinicalTrials.gov registry record

Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors

A clinical trial, sponsored by AdventHealth Translational Research Institute.

Completed
Registry status
8
Enrollment target

NCT02859116: Completed study, sponsored by AdventHealth Translational Research Institute.

NCT02859116 is a clinical trial that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02859116 has completed, sponsored by AdventHealth Translational Research Institute.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

The purpose of this study is to help scientists understand how the gut senses ingested nutrients and what kind of processes take place for their absorption in order to establish the association with diabetes and other metabolic diseases Scientists need human specimens to study.

Primary Outcome

During surgery, a tissue specimen that would normally be discarded, will be obtained and used to identify the localization and amount of different proteins that regulate nutrient absorption.

Interventions

  • PROCEDURE Collection of digestive tissues

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2016-07-21
Est. Completion 2022-01-21

What the finished NCT02859116 record still lists

NCT02859116 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Collection of digestive tissues is the first listed.

NCT02859116 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02859116 about?

NCT02859116 is a clinical study titled "Collection of Gastrointestinal Tissue Samples for the Characterization and ex Vivo Functional Assessment of Chemoreceptors". The purpose of this study is to help scientists understand how the gut senses ingested nutrients and what kind of processes take place for their absorption in order to establish the association with diabetes and other metabolic diseases Scientists need human specimens to study.

What is the current status of trial NCT02859116?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2016-07-21. Estimated completion is 2022-01-21.

What interventions are being tested in trial NCT02859116?

The interventions under investigation include: Collection of digestive tissues (PROCEDURE).

Who is sponsoring clinical trial NCT02859116?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02859116, the US trial registry maintained by the National Library of Medicine. NCT02859116 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.